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We report a case of Goodpasture’s syndrome following chronic low level and an acute, high level of exposure to crystalline
silica. A 38-year-old male tilesetter was admitted to the emergency room with dyspnea and respiratory failure. He reported that
his symptoms had developed over the previous week after inhaling a large amount of dust while dry-sanding and sweeping
a silica-based product used to ﬁll cracks in a cement ﬂoor. Over the following days, his pulmonary function declined and he
developed acute renal failure. Tests of antiglomerular basement membrane antibody were positive and renal biopsy revealed global
glomerulonephritis. He was diagnosed with Goodpasture’s syndrome and treated with steroids, plasmapheresis, and hemodialysis.
This man had a history of childhood asthma and a remote, one pack-year history of cigarette use. He used the ﬂooring product for
seven years prior to the inciting event, however, previous jobs had utilized signiﬁcantly smaller amounts. Goodpasture’s syndrome
and other autoimmune diseases have been reported in association with silica exposure. The acute onset following high level silica
exposure in this previously healthy man, suggest that clinicians should investigate silica exposure as a causal factor in cases of
Goodpasture’s syndrome.
1.Introduction
Goodpasture’s Syndrome is a rare autoimmune disease char-
acterized by pulmonary hemorrhage and glomerulonephri-
tis. Clinical features of Goodpasture’s Syndrome include
rapidly progressive renal failure and chest radiographs show
localized or diﬀuse alveolar shadowing. Renal biopsy is
needed to conﬁrm the diagnosis and reveals a crescentic
glomerulonephritis and ﬁbrinoid necrosis. In addition, diag-
nostic criteria include a positive anti-glomerular basement
membrane (GBM) antibody. Treatment for Goodpasture’s
Syndrome includes steroids, hemodialysis, and plasma-
pheresis. Disease progression can be halted with medical
intervention; however, renal and pulmonary damage can be
permanent.
Silica, also known as silicon dioxide, is a compound
commonly found in nature and is widely used. Silica is
a principal component in many products, including glass,
concrete, ceramics, food additives, insulation, concrete con-
struction, foundry castings, sandblasting, and paint, to name
a few. Many workers in the US are at risk of occupational
exposure to respirable crystalline silica, especially jobs in
industries such as construction, abrasive blasting, foundry
work, stonecutting, rock drilling, quarry work, and tunnel-
ing. Occupational exposures to respirable crystalline silica
are associated with the development of silicosis, a progressive
ﬁbrosisinthelung.Theseexposureshavealsobeenknownto
causeautoimmunediseasessuchasscleroderma,rheumatoid
arthritis, and glomerulonephritis [1]. Crystalline silica is
classiﬁed as a Group 1 carcinogen by the International
Agency for Research on Cancer. We describe here a 38-
year-old man who developed Goodpasture’s Syndrome after
chronic low level and an acute, high level exposure to
crystalline silica.
2. Case Presentation
A 38-year-old man presented to the emergency room
complaining of cough, dyspnea, and bloody sputum. When2 Case Reports in Medicine
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earlier, after inhaling a large amount of dust during his work
as a tilesetter. He reported that he had spent a three-day
period (8–10 days prior to presentation) sanding and dry-
sweeping a ﬂoor patching compound used to ﬁll cracks in
the cement ﬂoor. He had used this same material on many
smaller jobs, but this job utilized a much larger amount of
the patching material than he had used previously. He was
exposed to clouds of visible dust during the mixing, sanding,
and sweeping of the material. The compound contained
1% to 5% crystalline quartz silica. It was also noted that
the product was highly alkaline (pH = 12). He experienced
mucosal irritation while working, and had to go outside 3-4
additional times each workday to spit out dust and to “catch
his breath.” He felt ill each night after work. After the third
day of exposure he felt so poorly that he did not return to
work. Over the following weekend, his symptoms progressed
to chills and fever and he thought he had the ﬂu. He went
to walk-in clinic and was given antibiotics and an inhaler.
His pulmonary problems worsened that evening, prompting
him to present to the emergency room from where he was
admitted to the hospital.
The patient reported a history of childhood asthma and
a remote, one pack-year history of cigarette use. Physical
exam at presentation was remarkable for diﬀuse crackles
bilaterally and expiratory wheezes in all lung ﬁelds. After
two treatments with nebulized albuterol and Atrovent the
patient’s blood gas showed a pH of 7.45, PCO2 of 36, and
PO2 of 56 on room air. Chemistry panel, CPK, and troponin
levels were normal. White cell count was 17.7thou/cu
mm, hemoglobin 15g/dL, and hematocrit 42%. A chest
X-ray revealed abnormalities in the lung suggestive of a
diﬀuse interstitial pattern. Serial AFB tests and sputum
cultures were negative for mycobacterium, pneumocystis,
and streptococcus pneumoniae.
Twodaysafteradmissionthepatientbecameincreasingly
hypoxic and was intubated and put on a pressure ventilator.
Fiberoptic bronchoscopy revealed bloody secretions, and
BAL ﬂuid showed no particulate matter or evidence of
bacterialinfection.Transesophagealechocardiogramshowed
normal LV function, EF 65%, no signiﬁcant valvular
abnormalities, and a trivial pericardial eﬀusion. He did
not respond to oral antibiotics and made no progress in
weaning oﬀ ventilation, but rather progressed to severe
respiratory acidosis, with an arterial pH < 7.13 and pCO2
> 100mmHg one week after presentation. He subsequently
became unresponsive and developed oliguria and azotemia.
Urinalysis one week after presentation showed hematuria
and mild proteinuria consistent with glomerulonephritic
disease, as well as muddy brown casts characteristic of acute
tubular necrosis. At this time the patient tested positive for
the anti-GBM (glomerular basement membrane) antibody
and he was diagnosed with Goodpasture’s syndrome. This
was conﬁrmed by renal biopsy, which demonstrated global
glomerulosclerosis, focal hematuria, and linear immunoﬂu-
orescence reactions (IgG, IgM, C3) on glomerular basement
membranes. An open-lung biopsy revealed multifocal inter-
stitial ﬁbrosis, diﬀuse interstitial PMNs (polymorphonuclear
neutrophils), intravascular thrombi, and evidence of intra-
alveolardamage;aconstellationofsymptomsconsistentwith
Goodpasture’s syndrome. No polarizing particles were seen,
but immunoﬂuorescence studies revealed linear alveolar
septal IgG- and C3-immunoreactivity. Lung biopsy stains
also conclusively ruled out fungi, bacteria, pneumocystis,
and viral etiologies.
The patient was then treated with continuous hemoﬁl-
tration and dialysis, two weeks of plasmapheresis, and
immunosuppressive drugs including Cytoxan and pred-
nisone. Over the course of a three-month hospitalization the
patient suﬀered complications including sepsis and cerebral
hemorrhage, but renal function began to improve and he
wasgraduallyweanedoﬀventilation.Testsperformedduring
the fourth week of his hospitalization were negative for anti-
GBMantibody.Atdischarge,thepatientwasambulatoryand
able to breathe on his own, but demonstrated permanent
cognitive and motor impairment. Chest radiograph at this
time revealed persistent bibasilar atelectasis and interstitial
pulmonary edema. Subsequent outpatient pulmonary func-
tion testing demonstrated FEV-1 and FEV-1: FVC values
signiﬁcantly below predicted, consistent with the patient’s
reported symptoms and an obstructive picture. Quarterly
follow-up has shown no recurrence of Goodpasture’s syn-
drome, and the patient ceased immunosuppressive drugs
several months after his initial hospitalization. However,
the patient has required episodic treatment for recurrent
dyspnea and hemoptysis in the three years following his
initial disease onset and treatment due to lasting obstructive
pulmonary damage.
3. Discussion
Goodpasture’s Syndrome was ﬁrst described by Ernest
Goodpasture in 1919 and later named after him in 1958
[2]. This disease is characterized by pulmonary hemorrhage
and glomerulonephritis and is mediated by autoantibodies
directed against the basement membrane in the renal
glomerulus and the pulmonary alveolus. The etiology of
Goodpasture’s Syndrome is still unknown; however, devel-
opment of the disease following crystalline silica exposure
has been reported in at least three case reports [3–5].
Other exposures have also been implicated as causal factors,
including hydrocarbons [6, 7], cocaine use [8], hard metal
dust [9], and D-penicillamine [10]. The circumstances of
our case, a tilesetter with a minor history of tobacco use,
suggest inhalation of silica as the salient factor, although
some exposure to hydrocarbons is not uncommon amongst
workers in construction related jobs.
This patient started his 9-year career in ﬂooring work
as a helper and was later promoted to ﬂoor mechanic.
His job duties included mixing and applying compound,
leveling and sanding the ﬂoor, sweeping up excess dust and
debris, and physically laying tile or carpeting. No safety
equipment was ever used, including respirators or gloves.
He reports using the compound regularly in the seven
years leading up to his hospitalization. Details of other
chemical exposures during his career as a tilesetter are
unknown. Prior to working in the ﬂooring industry, theCase Reports in Medicine 3
patientbrieﬂyworkedasadriverforafeedstore,ataprinting
company, and at a glass company. He also worked for a pest
control company for seven years, where he reports wearing
protectiveequipment,includingglovesandrespiratorduring
job duties.
Information reported by this case indicates an intense
acute exposure to respirable silica prior to the onset of
disease. There was not an industrial hygienist present to
measure air levels during sanding and sweeping work at
his ﬁnal job, however, the patient reports that there were
consistently large dust clouds present on each of the three
workdaysandthatthequantityoftheﬂoorpatchingproduct
was tremendously greater than he had ever used in any job
prior. The exact amount of the patching compound used at
this site is unknown; however, purchasing record invoices
for the job totaled over 10,000 pounds. It is likely that the
case applied, sanded, and swept most, if not all, of the
product during his three days at the job. He used a small fan
to dry each application, but no dust controls, engineering
controls, or other ventilation controls were used. Given a
crystalline silica content of 1% to 5%, these factors indicate
a maximum potential for inhalation of a high quantity
of silica-containing dust prior to the onset of symptoms,
presumably far exceeding recommended occupational limits
(Table 1).
Crystalline silica is recognized as both a pneumotoxin
and nephrotoxin, and has been reported to cause multiple
autoimmune diseases [1]. As such, our case revealed severe
target organ toxicity to the lungs, kidneys, and other
target organ systems consistent with those reported in the
literature.
A multitude of epidemiological studies connect silica
exposure to various known autoimmune diseases [13–20].
Frequently reported diseases include scleroderma, systemic
lupus erythematosus, rheumatoid arthritis, autoimmune
hemolytic anemia, and sarcoidosis [1]. Several studies of
silica-exposed workers have shown increased rates of several
common autoimmune diseases, indicating that studies that
examine rates of only one disease may underestimate the
risks posed by silica exposure [21, 22].
Consistent with its correlation to autoimmune eﬀects,
epidemiological data has implicated silica as a cause of renal
disease [18, 23, 24]. A cohort study of 4,626 silica-exposed
workers showed comparatively high rates of mortality from
acuterenaldisease,chronicrenaldisease,andarthritis. There
was an excess in incidence of end-stage renal disease, which
was highest for glomerulonephritis. They found increasing
end-stage renal disease incidence with increasing cumulative
exposure [25]. Another study examined rates of renal
disease in a remote mining area in the United Kingdom, in
comparison to the nonmining areas of a clinical practice.
Statistical analysis conﬁrmed a signiﬁcant excess of renal dis-
ease, especially glomerulonephritis, in the mining area. The
authors propose that this excess is due to high silica exposure
inherent to ﬂuorspar mining. Of the six workers with long-
term silica exposure, ﬁve had glomerulonephritis proven by
biopsy and the other had signs and symptoms compatible
with chronic glomerulonephritis [26]. These ﬁndings are
consistent with other studies that show an increased risk
between silica exposure and glomerulonephritis [14, 27,
28].
Case reports also describe the acute onset of pulmonary,
renal, and autoimmune disease following silica exposure,
detailing clinical manifestations similar to our case pre-
sentation [29–33]. One case series presents four patients
who all developed rapidly progressive renal failure following
high-intensity silica dust exposure. Histological ﬁndings in
each case showed glomerular hypercellularity and sclerosis,
crescents, interstitial cellular inﬁltrates, and tubular necrosis.
Circulating immune complexes were present in three of
the patients, and electron microscopy showed electron-
dense glomerular basement membrane deposits in all of
the patients. Additionally, all four cases presented with
respiratory disease [34].
Simultaneous presence of lung and kidney failure fol-
lowing exposure to silica is not conﬁned to Goodpasture’s
Syndrome. In a case-controlstudy, the occupational histories
of 16 cases with a clear diagnosis of Wegener’s granulomato-
sis with renal involvement were compared with those of 32
matched controls. Wegener’s granulomatosis is a systemic
vasculitis with autoimmune and renal manifestations similar
to Goodpasture’s. Five cases reported exposure to silica dust
resulting in an odds ratio of 5.0 (95% CI 1.4–11.6) for
thisautoimmunediseasecomparedthenonexposedcontrols,
and seven cases reporting exposure to any silicon-containing
compounds yielded an odds ratio of 6.5 (95% CI 1.3–
13.5). Reported exposure to lead, cadmium, chromium,
welding fumes, and hydrocarbon was not associated with
a signiﬁcantly increased risk of Wegener’s granulomatosis
[35].
Available to us in the literature are three case reports
(four cases) linking chronic exposure to silica directly to
the development of Goodpasture’s syndrome. Stratta et
al., in a 2001 publication, proposed several reasons why
there are few studies and examples of crystalline silica-
related Goodpasture’s Syndrome present in the literature.
Reasons stated include limited records on patients with
acute symptoms leading to death, lack of renal clinical
data from the exposed workers, lack of correct diagnosis
from the hospitals and medical institutions carrying out the
dialysis, and relatively low occurrence to cross-reference to
occupational factors [36].
One report describes a 46-year-old foundry worker with
a history of intense exposure to respirable crystalline silica
that was admitted to the hospital with dyspnea, hematuria,
proteinuria, severe restrictive pulmonary function disorder,
and rapidly declining renal function. Immunological tests
and biopsy were positive for anti-GBM antibody and
pauci-immune crescentic glomerulonephritis, and he was
diagnosed with Goodpasture’s syndrome and treated by
hemodialysis and plasmapheresis. A workplace survey found
thattheexposurelevelofrespirablecrystallinesilicaexceeded
the exposure limit, a TLV-TWA of 0.0106mg/m3 which was
calibrated for overtime. The authors conclude that based on
his clinical presentation and industrial hygiene examination,
his Goodpasture’s syndrome was caused by long-term silica
exposure [3].4 Case Reports in Medicine
Table 1: Recommended exposure limits for respirable crystalline silica in occupational settings.
Agency Description Level
American Conference of Governmental
Industrial Hygienists (AGCIH) [11]
Threshold Limit Value (TLV)
Time Weighted Average (TWA)
0.025mg/m3
National Institute for Occupational Safety
and Health (NIOSH) [12] Recommended Exposure Limit (REL) 0.050mg/m3
Another case report discusses a 48-year-old male with
a history exposure to silica and lead while employed a
minimum of four years as a glazed-tile painter at a ceramic
tile factory. Characterization of silica is absent from the
report.Thisparticularcasewascomplicatedbyextensivelead
exposureandahistoryofacuteleadpoisoning[4].Oneother
case report implicated crystalline silica in the development
of Goodpasture’s Syndrome in two mine workers with
pneumoconiosis [5]. Levels of exposure are not described in
either report, although job histories reveal chronic exposure
over a number of years.
While studies suggest a causal relationship between silica
and autoimmune disease, the cellular mechanism is not
known. One theory is that when respirable silica particles
are encapsulated by macrophages, ﬁbrogenic proteins and
growth factors are generated, and ultimately the immune
system is activated [37–39]. Inhalation of large doses of
silica has been reported to increase mobilization from the
lungs into other organs including the kidney [40]. One
can therefore hypothesize that once silica has mobilized
into other organs, the immune system erroneously damages
normal tissues these organs. Some reports propose that silica
can induce multisystem disease through both activation of
the immune system and a direct tissue toxic eﬀect [34].
Furthermore, recent literature surveys suggest that silica has
an adjuvant eﬀect and nonspeciﬁcally enhances the immune
response, therefore, precipitating a variety of systematic
autoimmune diseases [15, 17]. A 2005 report by Brown et
al. focuses on potential mechanisms by which silica can lead
to the development and progression of autoimmune disease
[13].
Similarly, the pathogenesis of glomerulonephritis and
other renal eﬀects in silica-exposed workers is not estab-
lished. While some case reports provide evidence of an
immunologic injury by immune complex formation, others
point to a direct toxic eﬀect of silica [23, 41–43]. It has
also been postulated that since lung damage is found in
several kidney diseases, such as Goodpasture’s syndrome and
Wegener’s granulomatosis, then pulmonary insults may have
aroleinthedevelopmentofsomechronicrenaldiseases[44].
We speculate that the highly alkaline nature of the
product resulted in an irritating and corrosive eﬀect on the
mucous membranes of the upper respiratory tract when
inhaled. As a consequence of a mucous membrane injury,
our case would have likely ampliﬁed vulnerability to the
silica, increasing its absorption into the lung or submucousal
tissue.
Given the well-established health risks of silica dust
and the temporality of disease progression, we conclude
that our case of Goodpasture’s Syndrome was caused by
intense exposure to alkaline silica dust. This patient was in
good health prior to his acute exposure and had no prior
history of pulmonary, renal, or autoimmune disease. It is
likely that the high dose of respirable silica dust caused
his acute respiratory failure and initiated the progression of
autoimmune disease, which ultimately led to renal failure.
Following his recovery from the event, he never had any
recurrence of the illness, suggesting that the inciting event
was resolved. Multiple subsequent blood tests for anti-
glomerular basement membrane antibody came up negative.
Previous studies have focused on chronic rather than
acute occupational exposure to silica; however, evidence
suggests that the intensity of exposure rather than duration
seems to be important in selectively causing autoimmune
disorders [45]. Characterization of exposures during his
career is poor, however, this patient reports sanding and
sweeping the ﬂooring compound on many occasions during
a seven-year period leading up to his ﬁnal job. Whether
adequate exposure controls were in place during prior jobs
is unknown. We do know, however, that safety equipment,
such as respirators, were not used, and we can expect that
chronic exposure to respirable silica took place. However,
our case’s experience may be somewhat unique, as we believe
this to be the ﬁrst reported case in which there was an acute,
high-intensity exposure immediately preceding the onset of
development of Goodpasture’s Syndrome.
Construction workers face an increased risk of silica-
related disease due to their exposure while using, mixing,
cutting, grinding, and sanding concrete and/or silica-based
compounds. Over the past decades, techniques like dust sup-
pressionandincreaseduseofrespiratorshavelessenedhealth
risks to construction workers somewhat; yet, as our case
demonstrates,silicaexposureremainsapervasivehazardand
important cause of disease in exposed persons. This report
adds to the body of evidence supporting silica exposure as a
causal factor in cases of Goodpasture’s Syndrome.
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